trial · primary record
Biological: Solrikitug low dose
COPD
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 182 |
| Primary completion | 2027-02-01 |
| Primary endpoint | Change from baseline in blood eosinophil counts |
| Registry ID | NCT06496620 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:43:50.201Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06496620
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.